FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 99 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $283,000 | +28200.0% | 7,521 | +24161.3% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 31 | -82.7% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 179 | -46.2% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 333 | +4.1% | 0.00% | – |
| Q2 2019 | $2,000 | -97.6% | 320 | -94.8% | 0.00% | – |
| Q1 2019 | $82,000 | +2633.3% | 6,171 | +2119.8% | 0.00% | – |
| Q4 2018 | $3,000 | +50.0% | 278 | +55.3% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 179 | +678.3% | 0.00% | – |
| Q4 2016 | $1,000 | -99.9% | 23 | -99.9% | 0.00% | -100.0% |
| Q3 2016 | $1,349,000 | +10.7% | 25,708 | -12.8% | 0.00% | 0.0% |
| Q2 2016 | $1,219,000 | +3286.1% | 29,481 | +1521.6% | 0.00% | – |
| Q1 2014 | $36,000 | – | 1,818 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |